A 70-year-old woman with cold agglutinin disease (CAD) avoided disease-related complications from surgery related to a heart condition, in part because she took Enjaymo (sutimlimab-jome) before the operation for a heart condition, a case study from the U.S. reported. In addition to giving the woman Enjaymo, an approved…
Discussion
I made a decision on June 5, 1972, that has affected the rest of my life. Actually, that one decision rippled outward and affected many people worldwide, including my children, extended family, and students from six continents. On that day, my husband, Mike, and I stood before our families and…
Discussion
I left the doctor’s office feeling deeply conflicted, wondering whether I had made the right decision. I didn’t even look at the orders for a blood test before stuffing them into the back of my car seat. I had reached the end of my tolerance. I had just said no…
A woman with cold agglutinin disease (CAD) who was misdiagnosed with and treated for a blood cancer achieved lasting health improvements once doctors switched her to Enjaymo (sutimlimab-jome), a case study shows. The woman had initially received therapies for chronic lymphocytic leukemia (CLL). However, those treatments failed to…
A 78-year-old woman with cold agglutinin disease (CAD) was later found to have acute myeloid leukemia (AML), a type of blood cancer, which likely caused the disease, according to a case study from the U.S. Doctors discovered the woman’s AML after her anemia continued to worsen despite signs that…
Cold agglutinin disease (CAD) is a rare disorder in which the immune system mistakenly attacks red blood cells, resulting in anemia.
CAD is characterized by autoantibodies, called cold agglutinins, binding to and activating the destruction of red blood cells when exposed to cold temperatures.
Symptoms of CAD include fatigue, Raynaud’s syndrome, joint pain, jaundice or skin discoloration, and heart problems. These symptoms can worsen with more cold exposure.
Get regular updates to your inbox.
